抗凝固薬逆転薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00004954
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 154
Buy Now

[調査レポート]抗凝固薬回復薬市場は、2019年の9億2,255万米ドルから2027年までに22億7,654万米ドルに達すると予想されています。市場は、2020 年から 2027 年にかけて 12.6% の CAGR で成長すると推定されています。



抗凝固回復薬は、計画外の手術、抗凝固療法の過剰摂取、制御不能な治療などの特定の状況で抗凝固の効果を逆転させるために必要です。出血。抗凝固回復薬は、静脈血栓塞栓症、心房細動(AF)、機械弁置換術、抗リン脂質抗体症候群や第 V 因子ライデンなどのその他の凝固障害などの病状に使用されます。抗凝固拮抗薬市場の成長の主な要因は、心房細動(AFib)や脳卒中の有病率の上昇などです。しかし、抗凝固拮抗薬の高コストが市場の成長を制限しています。



抗凝固拮抗薬の収益性の高い地域市場



市場洞察



心房有病率の上昇細動 (AFib)



経口抗凝固薬は広く使用されており、AFib 患者の血栓塞栓症の予防に非常に効果的です。ただし、抗凝固剤の使用は心房細動患者に出血を引き起こす可能性があります。したがって、出血を防ぐために抗凝固作用を回復させる薬が使用されます。



疾病管理予防センター (CDC) によると、2018 年、米国では約 175,326 件の死亡診断書に心房細動が記載され、そのうち約 25,845 件の主な死因となっていました。さらに、米国では 2030 年までに 1,210 万人が AFib になると予想しています。



さらに、欧州心臓病学会 (ESC) によると、2016 年には 65 歳以上の人口が 760 万人となっています。 EU では心房細動を患っている人がおり、その数は 89% 増加して 2060 年までに 1,440 万人に達すると予想されています。同様に、脳卒中協会: 2017 年国家情勢によれば、英国では 100 万人以上が心房細動に苦しんでいます。細動。



したがって、世界中でこのように心房細動の有病率が高いことは、市場の成長を促進する可能性があります。



製品ベースの洞察



製品に基づいて、抗凝固逆転薬市場は、プロトロンビン複合体濃縮物、ビタミンK、プロタミン、トラネキサム酸、イダルシズマブ、およびAndeXXaに分割されています。プロトロンビン複合体濃縮物セグメントは、2019年に市場で最大のシェアを占めました。一方、AndeXXa セグメントは、予測期間中に市場で最も高い CAGR を記録すると推定されています。プロトロンビン複合体濃縮物は、新鮮凍結血漿に代わる信頼性の高い迅速な代替品として広く使用されており、過剰な出血を抑制します。



抗凝固薬逆転薬市場、製品別 - 2019 年および 2027 年



流通チャネルベースの洞察



流通チャネルに基づいて、抗凝固薬逆転薬市場は次のように分類されます。病院薬局、小売薬局など。病院薬局セグメントは 2019 年に市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると推定されています。



戦略的洞察



製品の発売と承認これらは、企業が世界的な拠点と製品ポートフォリオを拡大するために一般的に採用する戦略です。コラボレーションは、世界中の顧客ベースを拡大するために抗凝固薬逆転薬市場のプレーヤーが採用する主要な戦略の1つであり、これにより、ブランド名を世界的に維持することも可能になります。



抗凝固薬逆転薬市場 - 製品別





  • 濃縮プロトロンビン複合体

  • ビタミンK

  • プロタミン

  • トラネキサム酸

  • イダルシズマブ

  • AndeXXa


抗凝固薬回復薬市場 - 流通チャネル別





  • 病院薬局

  • 小売薬局

  • その他< /li>

抗凝固薬逆転薬市場 - 地理別





  • 北米

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • 英国< /li>
    • スペイン

    • ヨーロッパのその他の地域



  • アジア太平洋 (APAC)

    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア

    • その他のアジア太平洋地域



  • 中東およびアフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • アラブ首長国連邦

    • MEAのその他の地域

    • < /ul>
    • 南および中央アメリカ

      • ブラジル

      • アルゼンチン

      • その他の南および中央アメリカ




    会社概要





    • Boehringer Ingelheim International GmbH

    • Pfizer Inc

    • Octapharma AG

    • < li>Amag Pharmaceuticals, Inc
    • Fresenius Kabi AG

    • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)

    • CSL Limited

    • チャイナバイオロジックProducts, Inc

    • SA グリフォルズ

    • 上海 RAAS Blood Products Co., Ltd.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What anticoagulant reversal drugs?

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

What are the driving factors for the anticoagulant reversal drugs market across the globe?

The factors that are driving growth of the market are rise in prevalence of atrial fibrillation (AFib) and increase in prevalence of stroke are the major factors driving the market growth. However, high cost of anticoagulant reversal drugs is hindering the market growth.

Who are the major players in the anticoagulant reversal drugs market?

The anticoagulant reversal drugs market majorly consists of the players such as Boehringer Ingelheim International GmbH; Pfizer Inc; Octapharma AG; Amag Pharmaceuticals, Inc; Fresenius Kabi AG; Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals); CSL Limited; China Biologic Products, Inc; Grifols, S.A, and Shanghai RAAS Blood Products Co., Ltd. amongst others.

The List of Companies - Anticoagulant Reversal Drugs Market

  1. Boehringer Ingelheim International GmbH
  2. Pfizer Inc.
  3. Octapharma AG
  4. AMAG PHARMACEUTICALS, INC.
  5. Fresenius Kabi AG
  6. Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  7. CSL Limited
  8. China Biologic Products, Inc
  9. Grifols, S.A.
  10. Shanghai RAAS Blood Products Co.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports